Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer
Molecular Diagnosis & Therapy · 2025
DOI: 10.1007/s40291-024-00757-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Diagnosis & Therapy, 2025. Verfasst von Shijuan Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, 12700 East 19th …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Metabolomics, Proteomics, Genomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Defense, NCI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
To better understand ovarian cancer lethality and treatment resistance, sophisticated computational approaches are required that address the complexity of the tumor microenvironment, genomic heterogeneity, and tumor evolution. The ovarian cancer tumor ecosystem consists of multiple tumors and cell types that support disease growth and progression. Over the last two decades, there has been a revolution in -omic methodologies to broadly define components and essential processes within the tumor microenvironment, including transcriptomics, metabolomics, proteomics, genome sequencing, and single-cell analyses. While most of these technologies comprehensively characterize a single biological process, there is a need to understand the biological and clinical impact of integrating multiple -omics platforms. Overall, multi-omics is an intriguing analytic framework that can better approximate biological complexity; however, data aggregation and integration pipelines are not yet sufficient to reliably glean insights that affect clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Divisions of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, 12700 East 19th Avenue, MS 8613, Aurora, CO, 80045, USA.
- Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA.
- Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
- Divisions of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Denver, Anschutz Medical Campus, 12700 East 19th Avenue, MS 8613, Aurora, CO, 80045, USA. Benjamin.Bitler@cuanschutz.ed…
ORCID-Profile: Benjamin G Bitler
Förderung
- Department of Defense
- NCI NIH HHS
- NHGRI NIH HHS
- CSR NIH HHS
- NIAID NIH HHS
- Center for Scientific Review
Zitieren
APA
Lin, S., Nguyen, L. L., McMellen, A., Leibowitz, M. S., Davidson, N., Spinosa, D., & Bitler, B. G. (2025). Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00757-3
Vancouver
Lin S, Nguyen LL, McMellen A, Leibowitz MS, Davidson N, Spinosa D, et al. Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer. Molecular Diagnosis & Therapy. 2025. doi:10.1007/s40291-024-00757-3
BibTeX
@article{Lin2025,
author = {Lin, Shijuan and Nguyen, Lily L and McMellen, Alexandra and Leibowitz, Michael S and Davidson, Natalie and Spinosa, Daniel and Bitler, Benjamin G},
title = {Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer},
journal = {Molecular Diagnosis & Therapy},
year = {2025},
doi = {10.1007/s40291-024-00757-3}
}
EUVIMED